Back
Genmab AS Vs. UniFirst Industry Stock Comparison
Sell
35
GMAB
Genmab AS
Last Price:
$22.19
Seasonality Move:
6.65%
Buy
73
UNF
UniFirst
Last Price:
$214.87
Seasonality Move:
1.02%
Sell
35
Genmab AS (GMAB)
is a Sell
Is Genmab AS a Buy, Sell or Hold?
-
GMAB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GMAB Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.11 | Buy |
Relative Strength Index (14 RSI): | 64.22 | Buy |
Chaikin Money Flow: | 527837 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (20.35 - 21.81) | Buy |
Bollinger Bands (100): | (20.93 - 25.85) | Sell |
UNF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.65 | Sell |
Relative Strength Index (14 RSI): | 72.95 | Buy |
Chaikin Money Flow: | 380542 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (173.47 - 198.41) | Buy |
Bollinger Bands (100): | (180.75 - 197.95) | Buy |
GMAB Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 21.42 | Buy |
20-day SMA: | 20.9 | Buy |
50-day SMA: | 21.45 | Buy |
200-day SMA: | 25.67 | Sell |
8-day EMA: | 21.55 | Buy |
20-day EMA: | 21.22 | Buy |
50-day EMA: | 21.71 | Buy |
200-day EMA: | 25.24 | Sell |
UNF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 180.62 | Buy |
20-day SMA: | 183.05 | Buy |
50-day SMA: | 190.15 | Buy |
200-day SMA: | 178.74 | Buy |
8-day EMA: | 187.59 | Buy |
20-day EMA: | 185.11 | Buy |
50-day EMA: | 187.72 | Buy |
200-day EMA: | 182.46 | Buy |
Genmab AS Earnings Growth & GMAB Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.28 per share, and an increase next year of $0.72 per share.
UniFirst Earnings Growth & UNF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.35 per share, a decrease next quarter of $0.98 per share, a decrease this year of $0.14 per share, and an increase next year of $0.92 per share.
Genmab AS Technical Analysis
Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
UniFirst Technical Analysis
Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |